JP2014033663A - 核酸抽出装置及び核酸抽出方法 - Google Patents
核酸抽出装置及び核酸抽出方法 Download PDFInfo
- Publication number
- JP2014033663A JP2014033663A JP2012178144A JP2012178144A JP2014033663A JP 2014033663 A JP2014033663 A JP 2014033663A JP 2012178144 A JP2012178144 A JP 2012178144A JP 2012178144 A JP2012178144 A JP 2012178144A JP 2014033663 A JP2014033663 A JP 2014033663A
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- plug
- acid extraction
- tube
- solid phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 187
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 187
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 187
- 238000000605 extraction Methods 0.000 title claims abstract description 70
- 239000007790 solid phase Substances 0.000 claims abstract description 62
- 238000000034 method Methods 0.000 claims abstract description 18
- 238000005406 washing Methods 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims description 64
- 239000000126 substance Substances 0.000 claims description 23
- 238000005192 partition Methods 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 13
- 230000009089 cytolysis Effects 0.000 claims description 12
- 230000005484 gravity Effects 0.000 claims description 11
- 239000006166 lysate Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 5
- 230000002934 lysing effect Effects 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 4
- 239000000243 solution Substances 0.000 description 40
- 239000003921 oil Substances 0.000 description 32
- 239000000523 sample Substances 0.000 description 26
- 239000011324 bead Substances 0.000 description 23
- 150000003839 salts Chemical class 0.000 description 20
- 238000004140 cleaning Methods 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 15
- 230000003196 chaotropic effect Effects 0.000 description 14
- 102100034343 Integrase Human genes 0.000 description 13
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 12
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 241000700605 Viruses Species 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- -1 for example Chemical compound 0.000 description 7
- 238000010839 reverse transcription Methods 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 229920001971 elastomer Polymers 0.000 description 6
- 229960000789 guanidine hydrochloride Drugs 0.000 description 6
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000000696 magnetic material Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 3
- 241000271566 Aves Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 210000001167 myeloblast Anatomy 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241000714177 Murine leukemia virus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000000138 intercalating agent Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002683 reaction inhibitor Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- BAZAXWOYCMUHIX-UHFFFAOYSA-M sodium perchlorate Chemical compound [Na+].[O-]Cl(=O)(=O)=O BAZAXWOYCMUHIX-UHFFFAOYSA-M 0.000 description 1
- 229910001488 sodium perchlorate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012178144A JP2014033663A (ja) | 2012-08-10 | 2012-08-10 | 核酸抽出装置及び核酸抽出方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012178144A JP2014033663A (ja) | 2012-08-10 | 2012-08-10 | 核酸抽出装置及び核酸抽出方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014033663A true JP2014033663A (ja) | 2014-02-24 |
| JP2014033663A5 JP2014033663A5 (enExample) | 2015-09-03 |
Family
ID=50283057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012178144A Withdrawn JP2014033663A (ja) | 2012-08-10 | 2012-08-10 | 核酸抽出装置及び核酸抽出方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2014033663A (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015159754A (ja) * | 2014-02-27 | 2015-09-07 | セイコーエプソン株式会社 | 核酸増幅方法、核酸抽出用デバイス、核酸増幅反応用カートリッジ、及び核酸増幅反応用キット |
| JP2015159786A (ja) * | 2014-02-28 | 2015-09-07 | セイコーエプソン株式会社 | 標的物質の精製装置及び精製方法 |
| JP2015177770A (ja) * | 2014-03-19 | 2015-10-08 | セイコーエプソン株式会社 | 標的物質の精製装置、核酸精製装置、標的物質の生成方法、及び核酸増幅方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008012490A (ja) * | 2006-07-07 | 2008-01-24 | Shimadzu Corp | 微量化学反応方法及び装置 |
| WO2010147561A1 (en) * | 2009-06-16 | 2010-12-23 | Biochip Devises Pte Ltd | Method for conducting multiple reactions in a single reaction tube |
| WO2012086243A1 (ja) * | 2010-12-21 | 2012-06-28 | 株式会社 島津製作所 | 管内で対象成分を操作するためのデバイス及び方法 |
-
2012
- 2012-08-10 JP JP2012178144A patent/JP2014033663A/ja not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008012490A (ja) * | 2006-07-07 | 2008-01-24 | Shimadzu Corp | 微量化学反応方法及び装置 |
| WO2010147561A1 (en) * | 2009-06-16 | 2010-12-23 | Biochip Devises Pte Ltd | Method for conducting multiple reactions in a single reaction tube |
| WO2012086243A1 (ja) * | 2010-12-21 | 2012-06-28 | 株式会社 島津製作所 | 管内で対象成分を操作するためのデバイス及び方法 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015159754A (ja) * | 2014-02-27 | 2015-09-07 | セイコーエプソン株式会社 | 核酸増幅方法、核酸抽出用デバイス、核酸増幅反応用カートリッジ、及び核酸増幅反応用キット |
| JP2015159786A (ja) * | 2014-02-28 | 2015-09-07 | セイコーエプソン株式会社 | 標的物質の精製装置及び精製方法 |
| JP2015177770A (ja) * | 2014-03-19 | 2015-10-08 | セイコーエプソン株式会社 | 標的物質の精製装置、核酸精製装置、標的物質の生成方法、及び核酸増幅方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2725102B1 (en) | Nucleic acid extraction device, and nucleic acid extraction method, nucleic acid extraction kit, and nucleic acid extraction apparatus, each using the same | |
| US20200216832A1 (en) | Method and materials for isolation of nucleic acid materials | |
| US9624252B2 (en) | Selective nucleic acid fragment recovery | |
| JP5954532B2 (ja) | 核酸抽出用デバイス、核酸抽出用キット、核酸抽出用装置及び核酸抽出方法 | |
| JP2020190560A (ja) | 核酸サンプルを収集するためのシステム及び方法 | |
| US20110124851A1 (en) | Method of Isolation of Nucleic Acids | |
| JP2015084657A (ja) | 核酸抽出用デバイス | |
| CA2983623A1 (en) | Device and method for extraction of nucleic acids | |
| CN104673621A (zh) | 核酸扩增反应用容器、核酸扩增反应用筒及核酸扩增反应用筒试剂盒 | |
| US20150284710A1 (en) | Method of manipulating solid carriers and an apparatus of manipulating solid carriers | |
| JP2014033663A (ja) | 核酸抽出装置及び核酸抽出方法 | |
| US20150099279A1 (en) | Nucleic acid amplification method, nucleic acid extraction device, nucleic acid amplification reaction cartridge, and nucleic acid amplification reaction kit | |
| JP7068183B2 (ja) | 単一洗浄溶出バッファー溶液を使用する核酸精製システム | |
| JP2014083041A (ja) | 核酸抽出用装置 | |
| CN104862208A (zh) | 物质结合用固相载体的冷冻干燥体、制造方法以及容器 | |
| JP2014083040A (ja) | 核酸抽出用器具及びそれを用いた核酸抽出方法 | |
| JP2015073513A (ja) | 核酸抽出用デバイス、核酸抽出用キット、及び核酸抽出用装置 | |
| CN104419638A (zh) | 核酸扩增反应用盒 | |
| CN104877989A (zh) | 核酸扩增方法、核酸提取用设备、核酸扩增反应用盒、以及核酸扩增反应用套件 | |
| JP2017184626A (ja) | 核酸抽出キットおよび核酸抽出カートリッジ | |
| EP3337897B1 (en) | Method and system for isolation of nucleic acids | |
| US20150140649A1 (en) | Nucleic acid extraction device | |
| JP2016101097A (ja) | 核酸抽出用デバイス |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20150108 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150721 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150721 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160224 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160315 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160512 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20160609 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20160623 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160906 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20161104 |